Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01643954 · ClinicalTrials.gov registry record · NA

Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James

A NA study of Prostate Cancer, sponsored by Ohio State University Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
1,531
Enrollment target
1
Study location

NCT01643954 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 1,531 participants, above the 606-participant average among 735 other Prostate Cancer trials with a reported enrollment target (153% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01643954, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,531 participants
Enrollment target
1
Study location

Study Summary

This is a retrospective/prospective Analysis of surgical outcomes of robotic prostatectomy.

Conditions Studied

Interventions

  • PROCEDURE robotic radical prostatectomy

Study Locations (1)

Ohio

  • Ohio State University Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 1,531 participants
Start Date 2008-09-23
Est. Completion 2027-07-31
Phase NA

What the Registry Record Tells You About NCT01643954

The ClinicalTrials.gov registry entry for NCT01643954 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,531 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 606-participant average among 735 other Prostate Cancer trials with a reported enrollment target (153% higher). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which robotic radical prostatectomy is the first listed.

NCT01643954 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01643954 about?

NCT01643954 is a clinical study titled "Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James". This is a retrospective/prospective Analysis of surgical outcomes of robotic prostatectomy.

What is the current status of trial NCT01643954?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,531 participants. The study started on 2008-09-23. Estimated completion is 2027-07-31.

What conditions does trial NCT01643954 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT01643954?

The interventions under investigation include: robotic radical prostatectomy (PROCEDURE).

Who is sponsoring clinical trial NCT01643954?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01643954 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.